We serve Chemical Name:1-(Phenylsulfonyl)indole-3-sulfonyl chloride CAS:535930-73-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(Phenylsulfonyl)indole-3-sulfonyl chloride
CAS.NO:535930-73-5
Synonyms:1-(benzenesulfonyl)indole-3-sulfonyl chloride
Molecular Formula:C14H10ClNO4S2
Molecular Weight:355.81700
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:562.6ºC at 760 mmHg
Density:1.52g/cm3
Index of Refraction:1.673
PSA:89.97000
Exact Mass:354.97400
LogP:4.96740
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(benzenesulfonyl)indole-3-sulfonyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(benzenesulfonyl)indole-3-sulfonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(benzenesulfonyl)indole-3-sulfonyl chloride Use and application,1-(benzenesulfonyl)indole-3-sulfonyl chloride technical grade,usp/ep/jp grade.
Related News: And, while 89 percent of seniors nationwide are now protected by COVID-19 vaccinations, less than 70 percent of the seniors living in underserved communities have been vaccinated to prevent COVID-19 infections, hospitalizations and deaths. We must stay focused on helping the most at risk.
The ChenMed primary care practices at which 100 percent of doctors and staff have received COVID-19 vaccinations include: 100 percent of Chen Senior Medical Centers in Miami; 100 percent of Dedicated Senior Medical Centers in Cincinnati, Houston, Jacksonville, Lakeland, Philadelphia, St. Louis, and Tampa Bay (Bradenton, Clearwater, Largo, Tampa, St. Petersburg);
100 percent of JenCare Senior Medical Centers in Louisville, New Orleans, and Richmond. “We’re making great progress on getting all patient-facing staff vaccinated, and our company-wide goal remains 100 percent,” explains Dr. Lane.
ChenMed has long captured monthly patient feedback using third-party vendors to capture the accurate patient experience data needed to help its primary care physicians keep nurturing outstanding relationships with members.
For the month ending June 30, 2021, the Medallia Experience Cloud survey data shows a robust ChenMed Net Promoter Score (NPS) of 82.9 — substantively higher than many best-in-industry 2021 NPS benchmarks reported by NICE Satmetrix (after collecting more than 65,000 email surveys) for iconic customer brands including Apple (60); Ritz Carlton Hotel (66); USAA (70); Alaska Airlines (71); and Costco Wholesale Corporation (80).
Medalia also surveyed 1,057 ChenMed patients in June, finding:
84 percent said it is very important for their medical care team to be COVID-19 vaccinated.
79 percent (average age 72 years) of seniors reported being more comfortable visiting a medical center when all staff is fully vaccinated.
Noting how NPS can vary by industry, region, or customer characteristics including age, income level, or time with your company, Dr. Syed reports, “Our doctors stay focused on earning trust every day by delivering truly personalized primary care. We give our patients our cell phone numbers. We encourage walk-in appointments. We really practice medicine differently, and the results are outstanding. (E)-(S)-4-Benzylamino-5-methyl-hex-2-enoic acid ethyl ester manufacturers Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. 3-(3-amino-5-(((4-morpholinophenyl)amino)methyl)-1H-indol-2-yl)quinoxalin-2(1H)-one suppliers Researchers engineered IgM antibodies and found that in all cases, these antibodies were significantly more potent than standard IgG antibodies in neutralizing the COVID-19 virus. 6H-Naphtho[2,1-b][1,4]thiazin-6-one, 5-chloro-2,3-dihydro- vendor & factory.
The ChenMed primary care practices at which 100 percent of doctors and staff have received COVID-19 vaccinations include: 100 percent of Chen Senior Medical Centers in Miami; 100 percent of Dedicated Senior Medical Centers in Cincinnati, Houston, Jacksonville, Lakeland, Philadelphia, St. Louis, and Tampa Bay (Bradenton, Clearwater, Largo, Tampa, St. Petersburg);
100 percent of JenCare Senior Medical Centers in Louisville, New Orleans, and Richmond. “We’re making great progress on getting all patient-facing staff vaccinated, and our company-wide goal remains 100 percent,” explains Dr. Lane.
ChenMed has long captured monthly patient feedback using third-party vendors to capture the accurate patient experience data needed to help its primary care physicians keep nurturing outstanding relationships with members.
For the month ending June 30, 2021, the Medallia Experience Cloud survey data shows a robust ChenMed Net Promoter Score (NPS) of 82.9 — substantively higher than many best-in-industry 2021 NPS benchmarks reported by NICE Satmetrix (after collecting more than 65,000 email surveys) for iconic customer brands including Apple (60); Ritz Carlton Hotel (66); USAA (70); Alaska Airlines (71); and Costco Wholesale Corporation (80).
Medalia also surveyed 1,057 ChenMed patients in June, finding:
84 percent said it is very important for their medical care team to be COVID-19 vaccinated.
79 percent (average age 72 years) of seniors reported being more comfortable visiting a medical center when all staff is fully vaccinated.
Noting how NPS can vary by industry, region, or customer characteristics including age, income level, or time with your company, Dr. Syed reports, “Our doctors stay focused on earning trust every day by delivering truly personalized primary care. We give our patients our cell phone numbers. We encourage walk-in appointments. We really practice medicine differently, and the results are outstanding. (E)-(S)-4-Benzylamino-5-methyl-hex-2-enoic acid ethyl ester manufacturers Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. 3-(3-amino-5-(((4-morpholinophenyl)amino)methyl)-1H-indol-2-yl)quinoxalin-2(1H)-one suppliers Researchers engineered IgM antibodies and found that in all cases, these antibodies were significantly more potent than standard IgG antibodies in neutralizing the COVID-19 virus. 6H-Naphtho[2,1-b][1,4]thiazin-6-one, 5-chloro-2,3-dihydro- vendor & factory.
